Literature DB >> 3011077

Solubilization and reassembly of the mitochondrial benzodiazepine receptor.

R R Anholt, U Aebi, P L Pedersen, S H Snyder.   

Abstract

We have solubilized and reassembled the peripheral-type benzodiazepine receptor, a component of the mitochondrial outer membrane, from rat adrenal gland mitochondria. The ligand binding site of this receptor undergoes denaturation during solubilization in digitonin, Triton X-100, or 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate at detergent concentrations above 0.1%, which is evident from the loss of high-affinity binding of [3H]PK11195, a ligand selective for the mitochondrial benzodiazepine receptor. The conformation of the binding site for PK11195 can be stabilized during solubilization in sodium cholate by relatively low concentrations of supplementary soybean lipid. Drug displacement studies demonstrate that the pharmacological properties of the receptor are preserved under these conditions. Electron micrographs of the solubilized preparation show a heterogeneous population of many small particles (less than 100 A) and some larger membranous aggregates (up to 500 A). Sucrose gradient centrifugation indicates that these lipoprotein complexes are of high buoyant density. They can be incorporated in liposomes via cholate dialysis in the presence of additional supplementary lipid. The behavior of the mitochondrial benzodiazepine receptor during solubilization and reassembly suggests that it is an integral protein of the outer membrane.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011077     DOI: 10.1021/bi00356a041

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

Review 1.  Molecular mechanisms of peripheral benzodiazepine receptors.

Authors:  S H Snyder; M W McEnery; A Verma
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

2.  Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor.

Authors:  A Verma; J S Nye; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

3.  Age-related changes in peripheral benzodiazepine receptors of human platelets.

Authors:  D Marazziti; M L Pancioli-Guadagnucci; A Rotondo; G Giannaccini; C Martini; A Lucacchini; G B Cassano
Journal:  J Psychiatry Neurosci       Date:  1994-03       Impact factor: 6.186

4.  Relaxation of rat vascular muscle by peripheral benzodiazepine modulators.

Authors:  P Erne; M Chiesi; S Longoni; J Fulbright; K Hermsmeyer
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

5.  Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor.

Authors:  M J Besman; K Yanagibashi; T D Lee; M Kawamura; P F Hall; J E Shively
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

Review 6.  Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states.

Authors:  Malena B Rone; Jinjiang Fan; Vassilios Papadopoulos
Journal:  Biochim Biophys Acta       Date:  2009-03-12

7.  Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier.

Authors:  M W McEnery; A M Snowman; R R Trifiletti; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

8.  Liposome technology for industrial purposes.

Authors:  Andreas Wagner; Karola Vorauer-Uhl
Journal:  J Drug Deliv       Date:  2010-12-05

9.  Structure of the Mg-chelatase cofactor GUN4 reveals a novel hand-shaped fold for porphyrin binding.

Authors:  Mark A Verdecia; Robert M Larkin; Jean-Luc Ferrer; Roland Riek; Joanne Chory; Joseph P Noel
Journal:  PLoS Biol       Date:  2005-04-26       Impact factor: 8.029

10.  Changes in peripheral benzodiazepine receptors in patients with bipolar disorder.

Authors:  Donatella Marazziti; Bernardo Dell'Osso; Stefano Baroni; Irene Masala; Elena Di Nasso; Gino Giannaccini; Liliana Dell'Osso
Journal:  Neuropsychiatr Dis Treat       Date:  2005-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.